First New York Securities’s Quest Diagnostics DGX Stock Holding History

First New York Securities’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,624	Closed	-$99.8K	–	123
2015 Q3	$99.8K	Buy	+1,624	New	+$114K	0.05%	113
2015 Q1	–	Sell	-10,000	Closed	-$671K	–	404
2014 Q4	$671K	Buy	10,000 +9,769	+4,229%	+$616K	1.19%	19
2014 Q3	$4.66K	Buy	+231	New	+$14.2K	﹤0.01%	441

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First New York Securities's DGX Position: Q4 2015 in Review

First New York Securities sold out of Quest Diagnostics (DGX) in Q4 2015, closing a stake of 1,624 shares — an estimated $99.8K sold.

First New York Securities first reported a position in DGX in Q3 2014 and held it in 3 quarters. The position peaked at $671K in Q4 2014. 535 funds tracked by Wall St. Rank hold DGX as of Q4 2015.

First New York Securities reported no remaining Quest Diagnostics position as of Q4 2015 after selling out during the quarter.
First New York Securities sold 1,624 Quest Diagnostics shares in Q4 2015, an estimated $99.8K.
First New York Securities first reported a position in Quest Diagnostics in Q3 2014 and held it in 3 quarters.
First New York Securities's Quest Diagnostics position peaked at $671K in Q4 2014.
535 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2015.

Based on First New York Securities's 13F filing for Q4 2015, filed 25 Jan 2016.